Fed. Circ. Doubts PTAB Erred In Axing Almirall Acne Drug IP
A Federal Circuit panel seemed unlikely Wednesday to undo a win by Amneal Pharmaceuticals LLC at the Patent Trial and Appeal Board, which held that an Almirall LLC patent on its...To view the full article, register now.
Already a subscriber? Click here to view full article